Auris Health is an ambitious robotics company based in Silicon Valley. Auris was acquired for up to $6.1B by Johnson & Johnson in 2019.

Auris Health's vision begins with its Monarch Platform, an FDA-approved device that uses the latest advancements in robotics, software, data science and endoscope innovation to enter the body non-invasively to root out lung cancer.

• Industry

  • Hardware
  • Health + Tech
  • Robotics

• Milestones

  • Lux investment: 2012
  • Acquired by JNJ: 2019

• Founders

  • Fred Moll

  LUX Partners

  • Peter Hébert